What is a regulatory strategy? And for that matter, what do people sometimes think is a regulatory strategy but isn\u2019t? Those are the questions that today\u2019s guest, Mike Drues, discusses as he begins his conversation with host John Speer, founder of Greenlight Guru.
Mike is President of Vascular Sciences, an education, training, and consulting company that offers many services to medical device, pharmaceutical, and biotechnology companies. Listen to the episode to learn how Mike thinks about competitive regulatory strategy, delays in complying with regulation, and reimbursement and regulatory strategy.
\u201cLet\u2019s not forget my old friend, competitive regulatory strategy.\u201d
\u201cIt\u2019s never too soon, in my opinion, to start thinking about regulatory strategy.\u201d
\u201cAs a general rule, we have done an abysmal job on post-market surveillance across the board.\u201d
\u201cI consider this whole thing to be a poker game, in every sense of the word.\u201d